BioNeutra Global Corporation

BGACF · OTC
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$2,108-$2,921-$2,830-$3,707
Dep. & Amort.$1,058$1,111$1,324$1,841
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$483$0
Change in WC$1,697$2,440$777$2,839
Other Non-Cash$36$209$517$460
Operating Cash Flow$683$838$271$1,433
Investing Activities
PP&E Inv.-$19-$204-$277-$76
Net Acquisitions$0$7$0$50
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$1-$78$0$2
Investing Cash Flow-$21-$197-$277-$26
Financing Activities
Debt Repay.$1,106$121$52-$513
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$660-$439-$350-$387
Financing Cash Flow$446-$309-$298-$900
Forex Effect$57-$449$209-$96
Net Chg. in Cash$1,166-$117-$95$411
Supplemental Information
Beg. Cash$723$839$934$523
End Cash$1,889$723$839$934
Free Cash Flow$664$635-$6$1,357
BioNeutra Global Corporation (BGACF) Financial Statements & Key Stats | AlphaPilot